The BMSF DCTCDP application has two steps:
1) Letter of Intent (LOI)
2) Full Application (By invitation only)
Eligible candidates will reflect the National Science Foundation (NSF) definition of underrepresented populations in the US Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise:
OR have a demonstrated commitment to increasing diverse patient participation in clinical trials.
Citizenship or immigration status
Eligible candidates will be US Citizens or Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security. [NOTE: H-1B and O-1 Visa holders are eligible; the Visa must be valid during the full 2-yr period]
Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD
Eligible candidates will be Early-Stage Investigators (ESIs), defined by NIH as new investigators who have completed their terminal research degrees or medical residencies - whichever date is later - within the past 10 years and have not yet competed successfully for substantial NIH research grants. (Applicants with an RO1 or RO1 equivalent are ineligible.)
Letter of Intent (LOI) Submission Opens:
Oct 18, 2021
LOI Submission Closes:
Jan 14, 2022
Application Opens (By Invitation Only):
Jan 31, 2022
Apr 29, 2022
May 2 - Jul 31, 2022
Aug 1, 2022
Cohort 2 Begins:
Note: Dates are subject to change.
Copyright © 2020 Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program. All Rights Reserved.